- GlobeNewswire•2 days agoCelsion Presents Two Posters on its GEN-1 IL-12 Gene-Mediated Immunotherapy at the ASCO-SITC Clinical Immuno-Oncology Symposium
OVATION Study Fully Enrolled, Final Patient Enrolled in the Fourth Cohort. Complete Clinical and Translational Research Data to be Announced During the Second Quarter. LAWRENCEVILLE, N.J., Feb. 27, 2017-- ...
- Accesswire•8 days ago
NEW YORK, NY / ACCESSWIRE / February 21, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and micro-cap public companies, is covering Celsion ...
- GlobeNewswire•14 days ago
LAWRENCEVILLE, N.J., Feb. 15, 2017-- Celsion Corporation today announced the pricing of a public offering with expected total gross proceeds of approximately $5.0 million.. The offering was priced at $0.23 ...
CLSN : Summary for Celsion Corporation - Yahoo Finance
Celsion Corporation (CLSN)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Day's Range||0.22 - 0.23|
|52 Week Range||0.19 - 1.78|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.26|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|